Literature DB >> 7489411

The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway.

C Haass1, C A Lemere, A Capell, M Citron, P Seubert, D Schenk, L Lannfelt, D J Selkoe.   

Abstract

Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the beta-amyloid precursor protein (beta APP). A double mutation found in a Swedish family is located before the amyloid beta-peptide (A beta) region of beta APP and results in the increased production and secretion of A beta. Here we show that the increased production of A beta results from a cellular mechanism, which differs substantially from that responsible for the production of A beta from wild-type beta APP. In the latter case, A beta generation requires reinternalization and recycling of beta APP. In the case of the Swedish mutation the N-terminal beta-secretase cleavage of A beta occurs in Golgi-derived vesicles, most likely within secretory vesicles. Therefore, this cleavage occurs in the same compartment as the alpha-secretase cleavage, which normally prevents A beta production, explaining the increased A beta generation by a competition between alpha- and beta-secretase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489411     DOI: 10.1038/nm1295-1291

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  166 in total

1.  Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.

Authors:  W Xia; J Zhang; R Perez; E H Koo; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis.

Authors:  Tomomichi Watanabe; Yukiko Hikichi; Antje Willuweit; Yasushi Shintani; Takashi Horiguchi
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

Review 3.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

4.  ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.

Authors:  Peer-Hendrik Kuhn; Huanhuan Wang; Bastian Dislich; Alessio Colombo; Ulrike Zeitschel; Joachim W Ellwart; Elisabeth Kremmer; Steffen Rossner; Stefan F Lichtenthaler
Journal:  EMBO J       Date:  2010-07-30       Impact factor: 11.598

5.  Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse.

Authors:  Yajing Peng; Mi Jin Kim; Rikki Hullinger; Kenneth J O'Riordan; Corinna Burger; Mariana Pehar; Luigi Puglielli
Journal:  Brain       Date:  2016-01-19       Impact factor: 13.501

Review 6.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 7.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

8.  Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.

Authors:  Kulandaivelu S Vetrivel; Xavier Meckler; Ying Chen; Phuong D Nguyen; Nabil G Seidah; Robert Vassar; Philip C Wong; Masaki Fukata; Maria Z Kounnas; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

9.  Development of an Efficient Enzyme Production and Structure-Based Discovery Platform for BACE1 Inhibitors.

Authors:  Yu-Chen Yen; Annalissa M Kammeyer; Katherine C Jensen; Jagannadharao Tirlangi; Arun K Ghosh; Andrew D Mesecar
Journal:  Biochemistry       Date:  2019-10-22       Impact factor: 3.162

10.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.